MyFinsight
Home
About
Contact
flgt: the income statement
Download
Download image
Net loss
attributable to fulgent
-$6,608K
(54.89%↑ Y/Y)
Net loss
attributable to...
-$218K
(-373.91%↓ Y/Y)
Net loss from
consolidated operations
-$6,826K
(53.55%↑ Y/Y)
Benefit from income
taxes
-$683K
(82.20%↑ Y/Y)
Interest income
$7,874K
(-2.67%↓ Y/Y)
Clinical Patient
Contracts
$2,443K
Clinical Insurance
Contracts
$32,679K
Clinical Institutional
Contracts
$48,947K
Loss before income
taxes
-$7,509K
(59.48%↑ Y/Y)
Total other income
(expense), net
$7,841K
(639.64%↑ Y/Y)
Revenue
$84,069K
(17.18%↑ Y/Y)
Other (expense)
income, net
-$5K
(-100.92%↓ Y/Y)
Interest expense
$28K
(100.00%↑ Y/Y)
Operating loss
-$15,350K
(10.12%↑ Y/Y)
Gross profit
$35,512K
(32.65%↑ Y/Y)
Cost of revenue
$48,557K
(7.97%↑ Y/Y)
Total operating
expenses
$50,862K
(15.99%↑ Y/Y)
Amortization of intangible
assets
$2,025K
(1.61%↑ Y/Y)
General and
administrative
$23,335K
(11.38%↑ Y/Y)
Selling and marketing
$11,642K
(27.60%↑ Y/Y)
Research and development
$13,860K
(17.63%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc. (FLGT)